Stockreport

AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes

AngioDynamics, Inc.  (ANGO) 
Last angiodynamics, inc. earnings: 4/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.angiodynamics.com/investor-relations
PDF Multi-center, multi-national study to evaluate mechanical thrombectomy treatment in acute, intermediate-risk PE patients in European Market LATHAM, N.Y.--(BUSINESS WI [Read more]